MedPath

Ovariopexy for Adhesion Prevention After Laparoscopic Removal of Endometriosis of the Pelvic Side Wall or the Ovary

Not Applicable
Completed
Conditions
Adhesion
Endometriosis
Surgery
Registration Number
NCT04669756
Lead Sponsor
University Hospital Muenster
Brief Summary

prospective randomized Trial comparing ovariopexy over 2, 4 or 6 days vs Placebo after surgery because of endometriosis of the pelvic side wall or the ovary or both

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
409
Inclusion Criteria
  • premenopausal
  • wants to participate
  • removal of endometriosis of the pelvic side wall or ovary
Exclusion Criteria
  • postmenopausal
  • cannot give informed consent
  • no endometriosis during Operation
  • no Opening of pelvic side wall or ovary during the Operation
  • pregnant
  • breast feeding

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
prevalence of postoperative ovarian adhesions3 months after operation

prevalence of postoperative ovarian adhesions

Secondary Outcome Measures
NameTimeMethod
postoperative infectious complicationsup to 3 months after operation

postoperative infectious complications

postoperative paindaily during postoperative hospitalisation and at follow up visit after 3 months

postoperative pain (NRS)

AMHat follow up visit after 3 months

AMH level

Trial Locations

Locations (1)

University Hospital Muenster

🇩🇪

Münster, NRW, Germany

University Hospital Muenster
🇩🇪Münster, NRW, Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.